Modified ß-Galactosidase
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/JP2014/075575, filed Sep 26, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,465,219 | Modified ß-Galactosidase In force · High confidence | Amano Enzyme Inc. | In force | High confidence | ||
| US 11,555,214 | Modified ß-Galactosidase In force · High confidence | Amano Enzyme Inc. | In force | High confidence | ||
| Application 18/080,926 | Modified ß-Galactosidase Abandoned Abandoned Oct 21, 2024 | Amano Enzyme Inc. | Abandoned | Abandoned Oct 21, 2024 | ||
| Application 18/776,771 | MODIFIED ß-GALACTOSIDASE Pending Not granted | Amano Enzyme Inc. | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Amano Enzyme Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.